Delineate
PrivateLast Round
Seed
Mar 1, 2025
Total Funding Raised
$3.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Delineate operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in March 2025.
Delineate is a healthcare technology company that provides an AI-powered platform to accelerate clinical trial design and drug development by processing unstructured pharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delineate Comparables
Compare Delineate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Causaly | 78% | |
| Telperian | 75% | |
| IQVIA Holdings Inc. | 74% |
For institutional investors. Book with your work email.
Delineate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 1, 2025 | ||||
| Accelerator | Jan 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Delineate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator, Seed |
| Unpopular Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 35% MoM.
- May 25, 2026
Grew 28% QoQ, from 25 to 32 employees.
For institutional investors. Book with your work email.
Delineate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Delineate's valuation, stock price, and market status.
Is Delineate a public or private company?
Delineate is a private company.
What is the current stock price of Delineate?
Delineate is a private company, so its shares have no public market price. Caplight tracks Delineate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Delineate worth (valuation)?
Valuation information for Delineate is not publicly available.
Can I buy Delineate stock?
Delineate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Delineate's last funding round?
Delineate's most recent funding round was Seed on March 1, 2025.
Who are the main investors in Delineate?
Key investors in Delineate include Y Combinator.
Will Delineate IPO soon?
No public IPO plans have been announced for Delineate.
How can I track Delineate secondary market activity?
Caplight tracks bids, offers, and trades in Delineate's shares on secondary markets.